Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melvin E Andersen

Showing results (1-10 of 282) with videos related to

Pageof 29
Sort By:
Toxicology Letters|February 1, 2003
Toxicokinetic modeling and its applications in chemical risk assessmentMelvin E Andersen
Toxicologic Pathology|March 14, 2002
The use of quantitative histological and molecular data for risk assessment and biologically based model developmentMelvin E Andersen
Toxicology Letters|January 7, 2022
Assessing modes of action, measures of tissue dose and human relevance of rodent toxicity endpoints with octamethylcyclotetrasiloxane (D4)Melvin E Andersen
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 17, 2008
Toxicity testing in the 21st century: bringing the vision to lifeMelvin E Andersen, Daniel Krewski
ALTEX|January 18, 2011
A mechanistic redefinition of adverse effects - a key step in the toxicity testing paradigm shiftKim Boekelheide, Melvin E Andersen
Plos Computational Biology|March 6, 2007
Dose response relationship in anti-stress gene regulatory networksQiang Zhang, Melvin E Andersen
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 25, 2010
The vision of toxicity testing in the 21st century: moving from discussion to actionMelvin E Andersen, Daniel Krewski
Archives of Toxicology|January 31, 2007
The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiativeBas J Blaauboer, Melvin E Andersen
Mutagenesis|February 6, 2016
Approaches for characterizing threshold dose-response relationships for DNA-damage pathways involved in carcinogenicity in vivo and micronuclei formation in vitroRebecca A Clewell, Melvin E Andersen
Critical Reviews in Toxicology|November 25, 2004
Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethyleneHarvey J Clewell, Melvin E Andersen
Pageof 29

Showing results (1-10 of 282) with videos related to

Sort By:
Pageof 29
Toxicology Letters|February 1, 2003
Toxicokinetic modeling and its applications in chemical risk assessmentMelvin E Andersen
Toxicologic Pathology|March 14, 2002
The use of quantitative histological and molecular data for risk assessment and biologically based model developmentMelvin E Andersen
Toxicology Letters|January 7, 2022
Assessing modes of action, measures of tissue dose and human relevance of rodent toxicity endpoints with octamethylcyclotetrasiloxane (D4)Melvin E Andersen
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 17, 2008
Toxicity testing in the 21st century: bringing the vision to lifeMelvin E Andersen, Daniel Krewski
ALTEX|January 18, 2011
A mechanistic redefinition of adverse effects - a key step in the toxicity testing paradigm shiftKim Boekelheide, Melvin E Andersen
Plos Computational Biology|March 6, 2007
Dose response relationship in anti-stress gene regulatory networksQiang Zhang, Melvin E Andersen
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 25, 2010
The vision of toxicity testing in the 21st century: moving from discussion to actionMelvin E Andersen, Daniel Krewski
Archives of Toxicology|January 31, 2007
The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiativeBas J Blaauboer, Melvin E Andersen
Mutagenesis|February 6, 2016
Approaches for characterizing threshold dose-response relationships for DNA-damage pathways involved in carcinogenicity in vivo and micronuclei formation in vitroRebecca A Clewell, Melvin E Andersen
Critical Reviews in Toxicology|November 25, 2004
Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethyleneHarvey J Clewell, Melvin E Andersen
Pageof 29